Biotechnology News ABELCET Search

BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login

Search Results

Documents 1-5 out of 5 found

Current Search: abelcet: 5

Enzon Pharmaceuticals, Inc. - SWOT Analysis - New Research Report on Companies and Markets
Company-Profile/Enzon-Pharma ..

Enzon Pharmaceuticals, Inc.

SWOT company profile is the essential source for top-level company data and information.

The report examines the company's key business structure and operations, history and...

PR inside: Jul 2 2008 11:00PM
Matching: abelcet

Find similar documents

Enzon Eliminates Its Remaining 2008 Debt
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Enzon Pharmaceuticals, Inc.

(Nasdaq: ENZN - News) announced today it has successfully eliminated all of its remaining 2008 debt.

In December 2005 Enzon had approximately $400 million in outstanding 4.5...

Yahoo!: Jul 2 2008 1:55PM
Matching: abelcet

Find similar documents

Jack Geltosky, Ph.D. Joins Enzon's Board of Directors
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Enzon Pharmaceuticals, Inc.

(Nasdaq: ENZN - News) today announced that Dr.

Jack Geltosky has been appointed to the Company's Board of Directors.

" BRIDGEWATER, N.J.--(BUSINESS WIRE)--Enzon...

Business Wire via Yahoo!: May 28 2008 7:23PM
Matching: abelcet

Find similar documents

Enzon plans to spin-off biotech business
Enzon Pharmaceuticals, Inc.

has authorized a plan to spin-off its novel biotechnology business from Enzon in a transaction that will result in two independent and highly focused public companies.

'By separating these unique businesses...

PharmaBiz: May 9 2008 6:55AM
Matching: abelcet

Find similar documents

Enzon to spin off biotechnology business
Following the spin-off of the biotechnology company, Enzon will retain the current marketed products of Abelcet, Adagen, DepoCyt and Oncaspar, the rights to current PEG royalty revenues, including PEG-Intron, Cimzia and Hematide, and...

Pharmaceutical Business Review: May 9 2008 4:13AM
Matching: abelcet

Find similar documents

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright � 1997-2008 - BioPortfolio Limited.